Friday 8 February 2019

Start

End

Agenda

Speaker

8:00

08:30

Registration

Session I - Uro Oncology

Welcome Speech: Dr Khalid Rumaihi
Head of Urology Division at Hamad Medical Corporation, Urology MDT Lead clinician ad Chairman of Uro-oncology National Clinical Advisory Group

Session I [A]

Panel chairs – Dr. Khalid Al Jalham, Prof. Markus Hohenfellner

08:30

08:50

Active surveillance in prostate cancer 

Dr. Khalid Al Rumaihi
Head of Urology Division, Chair Uro-oncology MDT Lead and Chairman of Uro-oncology National Clinical Advisory Group. HMC

08:50

09:10

Surgical strategies and techniques for advanced kidney cancers in pediatrics and adults

Dr. Johanne N. Nyarangi-Dix
Senior medical officer and Deputy Clinic Director

09:10

09:30

The use of micronized amniotic graft in RRP and RLRP

Dr. Nagy Younes
Senior Consultant, Uro- Oncology. HMC

09:30

09:50

Epidemiology of Genito Urinary cancers in the Gulf region

Dr. Al Hareth Al Khater
Sr. Consultant Physician, Deputy Medical Director, National Center for Cancer Care & Research, Chairman, Corporate Healthcare Ethics Committee. HMC

09:50

09:55

Discussion - Q & A

09:55

10:15

Coffee Break

Session I [B]

Panel chairs – Dr. Khalid Al Rumaihi, Dr. Hareth Al Khater

10:15

10:35

Role of frozen section in genitourinary pathology

Dr. Issam Al-Bozom
Senior Consultant, Histopathology, Department of Laboratory Medicine and Pathology. HMC

10:35

10:55

State-of-the-Art continent bladder substitution

Prof. Markus Hohenfellner
Medical Director, Department of Urology, Heidelberg University Hospital

10:55

11:15

Role of Tailored Imaging and its Impact in Genito -urinary Malignancies

Dr. Maneesh Khanna
Senior Consultant, Radiology, Department of Clinical Imaging. HMC

11:15

11:35

Retzius-sparing (Bocciardi) approach for robotic radical prostatectomy

Prof. Markus Hohenfellner

11:35

11:55

Clinical experience of prostate cancer patients treated with radiotherapy in Qatar

Dr. Mohamed Riyas
Consultant, Radiation oncology core member in uro oncology MDT and Thoracic MDT.
Member in National clinical advisory group for Urological cancer and Lung cancer.

12:00

13:00

PRAYER & LUNCH

Session II - Head & Neck Oncology
Welcome Speech –  Dr. Hussain Al Enazi

Session II [A]

Panel chairs - Dr. Ahmed Own, Prof. Von Deimling

13:00

13:20

Keynote I
Role of immunotherapy in Head and Neck cancer

Dr. A. Rahman Gul
Senior Consultant Medical Oncology, NCCCR. HMC

13:20

13:40

Pterygopalatine fossa-major crossroads for tumor spread in the skull base.

Dr. Surjith Vattoth
Senior Consultant Neuroradiologist. HMC

13:40

14:10

Radiology of oral cavity and Oropharynx

Dr. Salman Qureshi: Consultant Head & Neck / Neuro Radiologist. Honorary Senior Lecturer University of Manchester. Executive Committee European Society Head Neck Radiology. HMC

14:10

14:30

Role of PET in Head and Neck malignancies

Dr. Zsolt Lengyel MD PhD
Clinical Lead of PET/CT
Senior Consultant, NCCCR, Clinical Imaging. HMC

14:30

14:35

Discussion - Q & A

14:35

14:55

Coffee Break

Session II [B]

Panel chairs - Dr. Mohammed Salim, Dr. Hussain Al Enaizi

14:55

15:15

The pathology of oral cancer in the state of Qatar: a comprehensive review

Dr. Adham Ammar
Senior Consultant, Histopathology, Department of Laboratory Medicine and Pathology. HMC

15:15

15:35

Post-radiotherapy salvage laryngectomy and pharyngectomy with free flap reconstruction

Prof. Philippe Federspil
Director of the Division of Oncological ORL Surgery at the University Hospital Heidelberg

15:35

15:55

Role radiotherapy in oral cavity cancer

Dr. Hissa Al-Abdulla/Dr Saju Divakar
Radiation Oncology Department, Consultant. NCCCR. HMC

15:55

16:15

Methylation based classification for precision diagnostics detects novel tumor entities”

Prof. A. von Deimling
Chairman Department of Neuropathology, University Heidelberg; and,
Head CCU Neuropathology, German Cancer Center

16:15

16:20

Discussion - Q & A

16:20

16:25

Closing Remarks